Year Established :
2002
Total Assets(USD) :
100,000,000 to 249,999,999
Total Number of Staff :
150 to 199
Main Competitive Advantages :
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Since it was founded, FarmaSino has been approved to engage in R&D, technology transfer, import, export and domestic trade of pharmaceuticals and chemicals. Scientific and quantified Standard Operation Procedure (SOP) has been formed to fit to itself
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
100,000,000 to 249,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Excipients,Natural Extracts,Bio Products,API Equipment,Fine Chemicals,Custom Manufacturing
Product Range :
Finished Drugs Tablets, Capsules, Liquid Injections, Powder for Injections, Miscellaneous Packing Materials, Surgicals, Animal Medicine.
Bulk Pharmaceuticals:
Active Pharmaceutical Ingredients, Veterinary Products, Amino Acids, Vitamins, Plant Ex
Eleven years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
